Description
TrenMix 200 is an oily injection solution containing three different Trenbolone esters: Trenbolone Acetate, Trenbolone Enanthate, and Trenbolone Hexahydrobenzylcarbonate. The typical split is at about 60-70mg/ml per ester, yielding a total concentration of about 200mg Trenbolone per ml.
Per study reports TrenMix combines the advantages of all three Tren esters in one injection: the acetate provides rapid onset (half-life ~3 days), the hex carries the middle phase (~5-7 days), the enanthate delivers the long plateau anchor (~7-10 days). This produces a remarkably smooth plasma level profile at moderate injection frequencies.
In practice TrenMix is typically injected twice per week. Pharmacology is identical to pure Trenbolone: high androgen receptor affinity, no aromatization, progestagenic residual action. All Tren effects (night sweats, sleep disturbances, aggression, prolactin-mediated symptoms, lipid profile worsening) are present under TrenMix.
The convenience of a three-ester mix comes with one disadvantage: mid-cycle adjustments are difficult because plasma level clearance through the long enanthate portion takes weeks. Research protocols with TrenMix are typically planned upfront as 8-12 week cycles.
Trenbolone is on the WADA banned list.
You can order TrenMix 200 as an oily injection solution in 10-pack at 200mg/ml.
This information is for research and educational purposes only. No medical recommendations.
Risks & Safety
TrenMix 200 bundles three Trenbolone esters into one injection - the risk profile described in the literature is identical to pure Trenbolone, and the high total concentration makes prolactin management especially relevant.
Documented in studies and the application literature:
- Progestagenic and prolactinergic action: Trenbolone acts progestagenically and drives prolactin levels up. Prolactin-mediated symptoms are documented. Trenbolone does not aromatize.
- Suppression of endogenous production: Trenbolone strongly suppresses endogenous testosterone production. Testicular atrophy and reduced fertility are documented, a separate test base is mandatory in research practice.
- Tren-typical effects: user reports describe night sweats, sleep disturbances and aggression. The long enanthate portion makes clearance take weeks if side effects occur.
- Cardiovascular and liver: the literature describes an unfavorable lipid profile, cardiac effects are documented in preclinical models. Hepatotoxicity is lower than under oral 17-alpha-methyl steroids but not negligible.
Baseline bloodwork before, during and after a research protocol is strongly advised. This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.
Studies
- 17β-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate - American Journal of Physiology-Endocrinology and Metabolism 2011, Yarrow et al: central study on trenbolone pharmacology. Shows tissue-selective anabolic action without aromatization in castrated rats.
- Characterisation of the affinity of different anabolics and synthetic hormones to the human androgen receptor, human sex hormone binding globulin and to the bovine progestin receptor - APMIS 2000, Bauer et al: quantifies the binding affinities of 17β-trenbolone for the androgen receptor and the progestin receptor, providing the basis for the progestagenic residual action of all Tren esters in the mix.
- Improvements in body composition, cardiometabolic risk factors and insulin sensitivity with trenbolone in normogonadic rats - Steroids 2015, Donner et al: documents the effects of trenbolone on body fat, lipid profile and insulin sensitivity in normogonadic rats over six weeks of administration.
- Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroids - International Journal of Drug Policy 2024, Piatkowski et al: cross-sectional study of 282 AAS users showing a dose-dependent association between trenbolone dose and verbal aggression.
- The Trenbolo(g)ne Sandwich: An International Study Comparing Health Harms Among Men Who Use Anabolic-Androgenic Steroids With and Without Trenbolone - Drug and Alcohol Review 2026, Bonenti et al: international comparative study between AAS users with and without trenbolone regarding documented health outcomes.
